While MCP-1 promotes vascular injury in the early stages of atherosclerosis, LOX-1 reportedly mediates not only endothelial dysfunction and inflammatory cell infiltration, but also atherosclerotic plaque formation, thrombogenesis, and platelet aggregation [21,22]. The gene discussed is CCL2; the disease is endothelial dysfunction.